Newsletter | November 17, 2026

11.17.26 -- Advancing Injectable Manufacturing At Scale

Accelerating Biologics Development From Cell Line To Commercial Supply

Move biologics from research and development toward commercialization with integrated development, analytics, scalable GMP manufacturing, and early-phase fill-finish capabilities.

Request Information

Cytovance Biologics

Accelerating Complex Injectable Programs

Accelerate complex injectable development with integrated capabilities in lipid nanoparticles, liposomes, sterile products, and combination devices.

Request Information

BE Biosol

Annex-1 Compliant Robotic Aseptic Powder Fill/Finish Solution

Precision, automated aseptic powder filling overcomes variability and scale‑up challenges, delivering accurate dosing, regulatory alignment, and a faster path from development to manufacturing.

Request Information

Dalton Pharma Services

Reducing Risk Across The Global Fill-Finish Supply Chain

Discover end-to-end drug product filling and packaging across our global network, designed to protect products and support seamless delivery to patients.

Request Information

FUJIFILM Biotechnologies

Advancing Sterile Fill-Finish For Injectable Therapies

The session will highlight the site’s advanced aseptic manufacturing infrastructure, automated filling technologies and scalable capacity designed to support clinical and commercial injectable products.

Request Information

Kindeva

Lonza Capabilities Update October 2026: Fill/Finish

Bastian Klöfer, Director of Commercial Development, Drug Product Services, explores Lonza's end-to-end biologics network, spanning drug substance, drug product development, manufacturing, analytics and regulatory support.

Request Information

Lonza

See How Fill4Sure Works

Dedicated fill lines for each needle eliminate the need to perform line splitting, minimizing the risk of fluid-path bottlenecks, cavitation for sensitive drug products, and structural weak points.

Request Information

Sanisure

New Facility, New Filling Line

A new sterile fill-finish facility and advanced filling line expand capacity, flexibility, and quality oversight, helping accelerate the path from clinical development to commercial supply.

Request Information

Grand River Aseptic Manufacturing

Explore Our New High-Speed Isolator Filling Line

High-speed fill-finish integrates automation, isolators, and scalable capacity to boost efficiency, protect product quality, and meet rising biologics demand from clinical through commercial. 

Request Information

IDT Biologika

Scaling Manufacturing Flexibility For Fill-Finish Commercial Success

Pharma and biotech developers rely on adaptable fill‑finish capacity to meet evolving market demands, scale products from clinical to commercial, and respond rapidly to public‑health emergencies.

Request Information

Jubilant HollisterStier

Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products

Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs.

Request Information

MilliporeSigma